Exercise & Sport Nutrition Lab
College Station, Texas, 77843-4253, United States
NCT Number: NCT04851899
Considering the important growing development of gaming in the world, this research area has developed considerably over the last few years. Even if it seems to be well admitted that video gamers showed better cognitive functions (e.g. visual selective attention, cognitive flexibility, task switching) parameters compared to non video gamers there is a constant concern for optimizing performance as for all other kind of athletes. However to our knowledge, only one randomized controlled trial have investigated the potential benefits of dietary supplementation on cognitive function and performance in video gamers. The use of microalgea as molecule of interest sources is a recent promising approach also to meet societal challenge as the maintain of biodiversity/landscape.
Thus, the purpose of this study is to examine whether acute (single-dose) and chronic (1 month) supplementation of Microphyt's phaeosol ingredients (BrainPhyt) ingested with or without a natural stimulant, would affect cognitive function and gaming performance in experienced video gamers.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
College Station, Texas, 77843-4253, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 Phaeosol softgel of 440mg/day and 1 placebo softgel of 500mg/day (look like softgel of Phaeosol product) + 1 capsule of 440mg/day of natural stimulant Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
2 Phaeosol softgels of 440mg/day + 1 capsule of 440mg/day of natural stimulant. Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
2 placebo softgels of 440mg/day (look like softgel of Phaeosol product) + 1 capsule of 500mg/day containing Microcellulose (look like capsule of natural stimulant). Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
Time frame: From week 0 to week 4
Change in reaction time - Light tracking test
Time frame: From week 0 to week 4
Change in general attention score - Go no go task test
Time frame: From week 0 to week 4
Change in sustained attention score - Psychomotor vigilance task test
Time frame: From week 0 to week 4
Change in attention shifting score - Berg-Washington card sorting task test
Time frame: From week 0 to week 4
Change in gaming performance score from 0 to 100 - Higher scores mean a better outcome
Time frame: From week 0 to week 4
Change in Mood state questionnaire score from 0 to 100 - Higher scores mean a better outcome - Profil of Mood state questionnaire
Time frame: From week 0 to week 4
Change in sleep quality questionnaire score from 0 to 100 - Higher scores mean a better outcome
Time frame: From week 0 to week 4
Change in eyes irritability score -Visual analogic scale from 0 to 100 - Higher scores mean a worse outcome
Time frame: From week 0 to week 4
Change in global fatigue score - Visual analogic scale from 0 to 100 - higher scores mean a worse outcome
Microphyt
Industry
Acronym: PHAEOSOL-TWO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05870072
Balance, Postural, Behavior
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07004023
Cognitive Function, Moderate Stress
London, Ontario, Canada
View Trial DetailsNCT07619976
Anaerobic Performance, Cognitive Function
Jacksonville, Alabama, United States
View Trial DetailsNCT06865027
Cerebral Perfusion Pressure, Circulation System
Lørenskog, Norway
View Trial Details